<?xml version="1.0" encoding="UTF-8"?>
<gtr:projectOverview xmlns:gtr="http://gtr.ukri.org/api"><gtr:projectComposition><gtr:collaborations><gtr:collaborator url="http://gtr.ukri.org:80/organisation/936D002F-A8D1-4A93-AE5D-825ED0903D8D"><gtr:id>936D002F-A8D1-4A93-AE5D-825ED0903D8D</gtr:id><gtr:name>University of Nottingham</gtr:name><gtr:address><gtr:line1>University Park</gtr:line1><gtr:line4>Nottingham</gtr:line4><gtr:line5>Nottinghamshire</gtr:line5><gtr:postCode>NG7 2RD</gtr:postCode><gtr:region>East Midlands</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/3EAE04CA-9D62-4483-B9C4-F91AD9F4C5A9"><gtr:id>3EAE04CA-9D62-4483-B9C4-F91AD9F4C5A9</gtr:id><gtr:name>University of Oxford</gtr:name><gtr:address><gtr:line1>University Chest</gtr:line1><gtr:line2>Wellington Square</gtr:line2><gtr:line4>Oxford</gtr:line4><gtr:postCode>OX1 2JD</gtr:postCode><gtr:region>South East</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/9C60CE47-6ED7-4C38-BF0D-BEE689253646"><gtr:id>9C60CE47-6ED7-4C38-BF0D-BEE689253646</gtr:id><gtr:name>Servier Laboratories</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/2DB7ED73-8E89-457A-A395-FAC12F929C1A"><gtr:id>2DB7ED73-8E89-457A-A395-FAC12F929C1A</gtr:id><gtr:name>University of Edinburgh</gtr:name><gtr:address><gtr:line1>Old College</gtr:line1><gtr:line2>South Bridge</gtr:line2><gtr:line3>Mayfield Road</gtr:line3><gtr:line4>Edinburgh</gtr:line4><gtr:postCode>EH8 9YL</gtr:postCode><gtr:region>Scotland</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/2400BE3D-876A-41C9-8178-94887A51CA1C"><gtr:id>2400BE3D-876A-41C9-8178-94887A51CA1C</gtr:id><gtr:name>University Hospitals Birmingham NHS Foundation Trust</gtr:name><gtr:address><gtr:line1>Metchley Park Road</gtr:line1><gtr:city>Birmingham</gtr:city><gtr:postCode>B15 2PR</gtr:postCode><gtr:region>West Midlands</gtr:region></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/9C10D78F-6430-4CA7-9528-B96B0762A4C6"><gtr:id>9C10D78F-6430-4CA7-9528-B96B0762A4C6</gtr:id><gtr:name>Cardiff University</gtr:name><gtr:address><gtr:line1>Research &amp; Consultancy</gtr:line1><gtr:line2>PO Box 923</gtr:line2><gtr:line4>Cardiff</gtr:line4><gtr:line5>South Glamorgan</gtr:line5><gtr:postCode>CF10 3TE</gtr:postCode><gtr:region>Wales</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/A1382653-9660-42B5-8658-B7FBD06F5D06"><gtr:id>A1382653-9660-42B5-8658-B7FBD06F5D06</gtr:id><gtr:name>AstraZeneca plc</gtr:name><gtr:address><gtr:line1>2 Kingdom Street</gtr:line1><gtr:postCode>W2 6BD</gtr:postCode><gtr:region>London</gtr:region></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/0483E310-F351-4F5A-BD4D-DAD6F8250918"><gtr:id>0483E310-F351-4F5A-BD4D-DAD6F8250918</gtr:id><gtr:name>Dainippon Sumitomo Pharma?Co</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/D1774113-D5D2-4B7C-A412-66A90FE4B96F"><gtr:id>D1774113-D5D2-4B7C-A412-66A90FE4B96F</gtr:id><gtr:name>University of Cambridge</gtr:name><gtr:address><gtr:line1>Lensfield Road</gtr:line1><gtr:line4>Cambridge</gtr:line4><gtr:postCode>CB2 1EW</gtr:postCode><gtr:region>East of England</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/E30CB640-027D-4603-9D2E-9A960744B123"><gtr:id>E30CB640-027D-4603-9D2E-9A960744B123</gtr:id><gtr:name>Autifony Therapeutics</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/68D0E3C9-9246-4CFC-B5E9-48584CF82993"><gtr:id>68D0E3C9-9246-4CFC-B5E9-48584CF82993</gtr:id><gtr:name>University of Manchester</gtr:name><gtr:address><gtr:line1>Oxford Road</gtr:line1><gtr:city>Manchester</gtr:city><gtr:postCode>M13 9PL</gtr:postCode><gtr:region>North West</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/318B5D98-4CB4-4B10-A876-08FC93071A56"><gtr:id>318B5D98-4CB4-4B10-A876-08FC93071A56</gtr:id><gtr:name>King's College London</gtr:name><gtr:address><gtr:line1>Capital House</gtr:line1><gtr:line2>2nd Floor, Guys Campus</gtr:line2><gtr:line3>42 Weston Street</gtr:line3><gtr:line4>London</gtr:line4><gtr:postCode>SE1 3QD</gtr:postCode><gtr:region>London</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address></gtr:collaborator></gtr:collaborations><gtr:leadResearchOrganisation url="http://gtr.ukri.org:80/organisation/68D0E3C9-9246-4CFC-B5E9-48584CF82993"><gtr:id>68D0E3C9-9246-4CFC-B5E9-48584CF82993</gtr:id><gtr:name>University of Manchester</gtr:name><gtr:department>Medical and Human Sciences</gtr:department><gtr:address><gtr:line1>Oxford Road</gtr:line1><gtr:city>Manchester</gtr:city><gtr:postCode>M13 9PL</gtr:postCode><gtr:region>North West</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:typeInd>RO</gtr:typeInd></gtr:leadResearchOrganisation><gtr:organisationRoles><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/68D0E3C9-9246-4CFC-B5E9-48584CF82993"><gtr:id>68D0E3C9-9246-4CFC-B5E9-48584CF82993</gtr:id><gtr:name>University of Manchester</gtr:name><gtr:address><gtr:line1>Oxford Road</gtr:line1><gtr:city>Manchester</gtr:city><gtr:postCode>M13 9PL</gtr:postCode><gtr:region>North West</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>LEAD_RO</gtr:name></gtr:role><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/936D002F-A8D1-4A93-AE5D-825ED0903D8D"><gtr:id>936D002F-A8D1-4A93-AE5D-825ED0903D8D</gtr:id><gtr:name>University of Nottingham</gtr:name><gtr:address><gtr:line1>University Park</gtr:line1><gtr:line4>Nottingham</gtr:line4><gtr:line5>Nottinghamshire</gtr:line5><gtr:postCode>NG7 2RD</gtr:postCode><gtr:region>East Midlands</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/3EAE04CA-9D62-4483-B9C4-F91AD9F4C5A9"><gtr:id>3EAE04CA-9D62-4483-B9C4-F91AD9F4C5A9</gtr:id><gtr:name>University of Oxford</gtr:name><gtr:address><gtr:line1>University Chest</gtr:line1><gtr:line2>Wellington Square</gtr:line2><gtr:line4>Oxford</gtr:line4><gtr:postCode>OX1 2JD</gtr:postCode><gtr:region>South East</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/9C60CE47-6ED7-4C38-BF0D-BEE689253646"><gtr:id>9C60CE47-6ED7-4C38-BF0D-BEE689253646</gtr:id><gtr:name>Servier Laboratories</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/2DB7ED73-8E89-457A-A395-FAC12F929C1A"><gtr:id>2DB7ED73-8E89-457A-A395-FAC12F929C1A</gtr:id><gtr:name>University of Edinburgh</gtr:name><gtr:address><gtr:line1>Old College</gtr:line1><gtr:line2>South Bridge</gtr:line2><gtr:line3>Mayfield Road</gtr:line3><gtr:line4>Edinburgh</gtr:line4><gtr:postCode>EH8 9YL</gtr:postCode><gtr:region>Scotland</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/2400BE3D-876A-41C9-8178-94887A51CA1C"><gtr:id>2400BE3D-876A-41C9-8178-94887A51CA1C</gtr:id><gtr:name>University Hospitals Birmingham NHS Foundation Trust</gtr:name><gtr:address><gtr:line1>Metchley Park Road</gtr:line1><gtr:city>Birmingham</gtr:city><gtr:postCode>B15 2PR</gtr:postCode><gtr:region>West Midlands</gtr:region></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/9C10D78F-6430-4CA7-9528-B96B0762A4C6"><gtr:id>9C10D78F-6430-4CA7-9528-B96B0762A4C6</gtr:id><gtr:name>Cardiff University</gtr:name><gtr:address><gtr:line1>Research &amp; Consultancy</gtr:line1><gtr:line2>PO Box 923</gtr:line2><gtr:line4>Cardiff</gtr:line4><gtr:line5>South Glamorgan</gtr:line5><gtr:postCode>CF10 3TE</gtr:postCode><gtr:region>Wales</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/A1382653-9660-42B5-8658-B7FBD06F5D06"><gtr:id>A1382653-9660-42B5-8658-B7FBD06F5D06</gtr:id><gtr:name>AstraZeneca plc</gtr:name><gtr:address><gtr:line1>2 Kingdom Street</gtr:line1><gtr:postCode>W2 6BD</gtr:postCode><gtr:region>London</gtr:region></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/0483E310-F351-4F5A-BD4D-DAD6F8250918"><gtr:id>0483E310-F351-4F5A-BD4D-DAD6F8250918</gtr:id><gtr:name>Dainippon Sumitomo Pharma?Co</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/D1774113-D5D2-4B7C-A412-66A90FE4B96F"><gtr:id>D1774113-D5D2-4B7C-A412-66A90FE4B96F</gtr:id><gtr:name>University of Cambridge</gtr:name><gtr:address><gtr:line1>Lensfield Road</gtr:line1><gtr:line4>Cambridge</gtr:line4><gtr:postCode>CB2 1EW</gtr:postCode><gtr:region>East of England</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/E30CB640-027D-4603-9D2E-9A960744B123"><gtr:id>E30CB640-027D-4603-9D2E-9A960744B123</gtr:id><gtr:name>Autifony Therapeutics</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/318B5D98-4CB4-4B10-A876-08FC93071A56"><gtr:id>318B5D98-4CB4-4B10-A876-08FC93071A56</gtr:id><gtr:name>King's College London</gtr:name><gtr:address><gtr:line1>Capital House</gtr:line1><gtr:line2>2nd Floor, Guys Campus</gtr:line2><gtr:line3>42 Weston Street</gtr:line3><gtr:line4>London</gtr:line4><gtr:postCode>SE1 3QD</gtr:postCode><gtr:region>London</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole></gtr:organisationRoles><gtr:personRoles><gtr:personRole url="http://gtr.ukri.org:80/person/DC247267-DA2E-47CD-838A-348F17241C68"><gtr:id>DC247267-DA2E-47CD-838A-348F17241C68</gtr:id><gtr:firstName>Nancy</gtr:firstName><gtr:otherNames>Jane</gtr:otherNames><gtr:surname>Rothwell</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.ukri.org:80/person/A0740019-B847-40B7-8504-8AA5AF6E45FC"><gtr:id>A0740019-B847-40B7-8504-8AA5AF6E45FC</gtr:id><gtr:firstName>Anthony</gtr:firstName><gtr:otherNames>Kenneth</gtr:otherNames><gtr:surname>Jones</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.ukri.org:80/person/F50D0FEB-23E7-4059-B665-EDE58E32CF97"><gtr:id>F50D0FEB-23E7-4059-B665-EDE58E32CF97</gtr:id><gtr:firstName>Graham</gtr:firstName><gtr:otherNames>Robert</gtr:otherNames><gtr:surname>Barnes</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.ukri.org:80/person/F0A3F403-8578-47AC-A520-9E6B1EDFC18F"><gtr:id>F0A3F403-8578-47AC-A520-9E6B1EDFC18F</gtr:id><gtr:firstName>Bill</gtr:firstName><gtr:surname>Deakin</gtr:surname><gtr:orcidId>0000-0002-2750-962X</gtr:orcidId><gtr:roles><gtr:role><gtr:name>PRINCIPAL_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.ukri.org:80/person/DD273593-1D6E-492D-8E50-FFC6D2D2E976"><gtr:id>DD273593-1D6E-492D-8E50-FFC6D2D2E976</gtr:id><gtr:firstName>Stephen</gtr:firstName><gtr:otherNames>Ross</gtr:otherNames><gtr:surname>Williams</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole></gtr:personRoles><gtr:project url="http://gtr.ukri.org:80/projects?ref=G0300653"><gtr:id>DC199E65-8790-4B74-B78B-2B65B0BED1DF</gtr:id><gtr:title>Manchester Magnetic Resonance Neuroimaging Co-operative</gtr:title><gtr:status>Closed</gtr:status><gtr:grantCategory>Research Grant</gtr:grantCategory><gtr:grantReference>G0300653</gtr:grantReference><gtr:abstractText>Functional imaging is increasingly becoming an important tool in Neuroscience. It provides a way of identifying the regions in the human brain which are active during various tasks. The technique is safe, entirely non-invasive and can be applied equally to volunteers and clinical patients. In this group, there are researchers who are interested in how the brain processes chronic pain (particularly in arthritis), how eye-hand movements are co-ordinated, what brain regions may function differently in individuals in anti-social personality disorder, how inflammation plays a role in the development of brain damage following stroke, and how recovery of function after a stroke can be helped. Although the problems are diverse, the methods used to investigate them have much in common, using a core of similar techniques. By bringing the researchers together under the umbrella of a co-operative group, interchange of ideas will be facilitated and methods developed in one area of research will be available to the other groups to exploit in their own programmes. In addition, the co-operative will foster collaboration between research groups led by people in different disciplines, including basic scientists, physicians and psychiatrists.</gtr:abstractText><gtr:technicalSummary>The aim of the co-operative group is to develop and implement improved methods for imaging-based research in order to underpin a range of projects utilising functional MR in the study of basic and clinical neuroscience, concentrating initially on pain, stroke, personality disorder and visuo-motor control. We are also requesting funds for a new component grant to investigate cortical plasticity. The proposed co-op will also provide a means to share technical support &amp;amp; scientific expertise amongst the members. Recent investment in imaging and new appointments by the University of Manchester and UMIST, together with support from the MRC and industry has resulted in a significant improvement in the facilities available for MR imaging. The proposed co-operative will have access to two new state-of-the-art scanners: a 1.5T Philips Intera sited in the Wellcome Trust Clinical Research Facility and a 3.0T Philips Intera-Achieva scanner (the first installation worldwide of this system) situated at Hope Hospital, Salford, where the University?s Clinical Neuroscience activity is based. Recognizing that multi-disciplinary working and good communication between user groups is the best way to exploit the benefits of the new scanners, we believe that a co-operative group will provide one important element in an overall strategy. In particular, the co-op will undertake development of core MR techniques to take advantage of the enhanced capabilities of the new scanners (high performance gradients - 60 mT/m on both scanners; parallel imaging, high field imaging) and make these available to all users of the systems. The remit of the co-op will go beyond the scientific and clinical objectives of the current components, and identify anatomical substrates and neurochemical mechanisms underlying plasticity, serious mental disorders, chronic pain, stroke pathogensis and motor programming. This work should in turn lead to clinical benefit through the development of appropriate therapies and of methods to evaluate them objectively. In collaboration with the Translational Imaging Unit, established by the University to manage the new imaging facilities, the co-op will aim to provide first class facilities for carrying out MR neuroimaging; support biological and clinical scientists to carry out MR studies, and to encourage a collaborative culture in which research topics and problems are openly discussed.</gtr:technicalSummary><gtr:fund><gtr:end>2010-07-03</gtr:end><gtr:funder url="http://gtr.ukri.org:80/organisation/C008C651-F5B0-4859-A334-5F574AB6B57C"><gtr:id>C008C651-F5B0-4859-A334-5F574AB6B57C</gtr:id><gtr:name>MRC</gtr:name></gtr:funder><gtr:start>2005-07-04</gtr:start><gtr:type>INCOME_ACTUAL</gtr:type><gtr:valuePounds>143495</gtr:valuePounds></gtr:fund><gtr:output><gtr:artisticAndCreativeProductOutputs/><gtr:collaborationOutputs><gtr:collaborationOutput><gtr:collaboratingOrganisation>King's College London</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>Institute of Psychiatry, Psychology &amp; Neuroscience</gtr:department><gtr:description>BeneMin</gtr:description><gtr:id>816B9386-5E06-4931-8554-A2822F31F89C</gtr:id><gtr:impact>in pregress</gtr:impact><gtr:outcomeId>548ae019c83c37.54084488-2</gtr:outcomeId><gtr:partnerContribution>Recruitment of patients</gtr:partnerContribution><gtr:piContribution>We lead the BeneMin clinic trial of minocycline in early psychosis. EME/NIHR grant</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2011-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Autifony Therapeutics</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:description>Autifony</gtr:description><gtr:id>592F752C-CAC5-4D9C-8088-695E06CC260A</gtr:id><gtr:impact>No outcomes yet</gtr:impact><gtr:outcomeId>548adc94a1be47.77674782-1</gtr:outcomeId><gtr:partnerContribution>Funding. Compounds. Scientific expertise</gtr:partnerContribution><gtr:piContribution>Screening Autifony compounds in preclinical models of efficacy. Phase 1 evaluation of novel Autifony compound underway in heathy volunteers to demonstrate target engagement and efficacy. Does the drug antagonise the subjective and brain imaging effects of ketamine?</gtr:piContribution><gtr:sector>Private</gtr:sector><gtr:start>2013-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Nottingham</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>Sir Peter Mansfield Magnetic Resonance Centre</gtr:department><gtr:description>MRC Spring study</gtr:description><gtr:id>8DE54492-3BA4-43D1-AAAD-BA45EE7E89DE</gtr:id><gtr:impact>Just starting</gtr:impact><gtr:outcomeId>548ad7bab12940.31054402-1</gtr:outcomeId><gtr:partnerContribution>3 centre collaboration to recruit patients with early and established psychosis for biomarkers of glutamate, GABA neurochemistry and function in early psychosis</gtr:partnerContribution><gtr:piContribution>Cubric: magneto ecncepahalography (MEG) &amp;amp; magnetic resonance spectroscopy (MRS)
Nottingham: MEG and c13 MRS</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2013-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Servier Laboratories</gtr:collaboratingOrganisation><gtr:country>France, French Republic</gtr:country><gtr:description>Servier</gtr:description><gtr:id>986ED87C-0DE2-4104-A234-1B720E06BD0B</gtr:id><gtr:impact>Internal company report. Abstracts at neuroscience and imaging meetings. Papers under preparation</gtr:impact><gtr:outcomeId>28CDB58C03E-1</gtr:outcomeId><gtr:partnerContribution>Access to a new drug for testing</gtr:partnerContribution><gtr:piContribution>Pharmacological-challenge fMRI was used to image the effects of a novel anti-depressant on the brain</gtr:piContribution><gtr:sector>Private</gtr:sector><gtr:start>2006-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Oxford</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>Department of Physiology, Anatomy and Genetics</gtr:department><gtr:description>AZ funded comparison ketamine vs AZD6765 phMRI</gtr:description><gtr:id>5F830E02-696E-4753-AB37-5A18A2934FAD</gtr:id><gtr:impact>5 conference presentations and a poster prize.
I Publication PMID: 27133029</gtr:impact><gtr:outcomeId>LUwZoKMGB1T-2</gtr:outcomeId><gtr:partnerContribution>Funding for MRI scans and RA salaries and investigator time</gtr:partnerContribution><gtr:piContribution>The coop facilitated the development of a novel method of imaging the direct effects of a drug on brain function, called the p-block method of pharmaco MRI. This a potentially important way of evaluating the actions of new compounds in development.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2010-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>King's College London</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>Clinical Neuroscience</gtr:department><gtr:description>BeneMin</gtr:description><gtr:id>1BE50C06-3A32-47BE-809B-07B4E5F1998E</gtr:id><gtr:impact>in pregress</gtr:impact><gtr:outcomeId>548ae019c83c37.54084488-3</gtr:outcomeId><gtr:partnerContribution>Recruitment of patients</gtr:partnerContribution><gtr:piContribution>We lead the BeneMin clinic trial of minocycline in early psychosis. EME/NIHR grant</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2011-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Edinburgh</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>Division of Psychiatry</gtr:department><gtr:description>BeneMin</gtr:description><gtr:id>89CB9EBD-B791-49B7-BDEA-C364A1A78200</gtr:id><gtr:impact>in pregress</gtr:impact><gtr:outcomeId>548ae019c83c37.54084488-4</gtr:outcomeId><gtr:partnerContribution>Recruitment of patients</gtr:partnerContribution><gtr:piContribution>We lead the BeneMin clinic trial of minocycline in early psychosis. EME/NIHR grant</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2011-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Manchester</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>Faculty of Life Sciences</gtr:department><gtr:description>Manchester PET imaging aggression</gtr:description><gtr:id>B2BA2E02-C71E-4DAA-835C-1B467BC6E20A</gtr:id><gtr:impact>Publication in press</gtr:impact><gtr:outcomeId>Wmcmzj5uACJ-1</gtr:outcomeId><gtr:piContribution>A PET imaging study has been carried out of the brain 5HT transporter andf 5HT2A receptor in impulsive aggressive individuals. Current analysis of genetic association with PET markers</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2007-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Cambridge</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>Department of Psychiatry</gtr:department><gtr:description>BeneMin</gtr:description><gtr:id>36443D93-7A0A-4CEE-BD63-C50F74498318</gtr:id><gtr:impact>in pregress</gtr:impact><gtr:outcomeId>548ae019c83c37.54084488-5</gtr:outcomeId><gtr:partnerContribution>Recruitment of patients</gtr:partnerContribution><gtr:piContribution>We lead the BeneMin clinic trial of minocycline in early psychosis. EME/NIHR grant</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2011-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University Hospitals Birmingham NHS Foundation Trust</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>Queen Elizabeth Medical Centre, Birmingham</gtr:department><gtr:description>BeneMin</gtr:description><gtr:id>E784898A-FFB0-433B-A0D7-FAC5EAD5115A</gtr:id><gtr:impact>in pregress</gtr:impact><gtr:outcomeId>548ae019c83c37.54084488-1</gtr:outcomeId><gtr:partnerContribution>Recruitment of patients</gtr:partnerContribution><gtr:piContribution>We lead the BeneMin clinic trial of minocycline in early psychosis. EME/NIHR grant</gtr:piContribution><gtr:sector>Hospitals</gtr:sector><gtr:start>2011-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>AstraZeneca</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:description>AZ chronic citalopram study</gtr:description><gtr:id>68E48E73-BB04-4DC9-8E4B-401E3338E496</gtr:id><gtr:impact>abstracts at imaging meetings. Internal company report, papers in preparation</gtr:impact><gtr:outcomeId>F3EC8E0E29E-1</gtr:outcomeId><gtr:partnerContribution>Funded an original study to look at brain plasticity following SSRI treatment</gtr:partnerContribution><gtr:piContribution>pharmacological-challenge fMRI study of the effects of an SSRI on regional brain activation. SSRI challenge was tested before and after treatment for 11d with therapeutic dose of SSRI or placebo</gtr:piContribution><gtr:sector>Private</gtr:sector><gtr:start>2006-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Dainippon Sumitomo Pharma?Co</gtr:collaboratingOrganisation><gtr:country>United States of America</gtr:country><gtr:department>Sunovion</gtr:department><gtr:description>Sunovion</gtr:description><gtr:id>F1638273-56ED-4C2E-98EB-1B447B8590A1</gtr:id><gtr:impact>None yet</gtr:impact><gtr:outcomeId>548adbb0de8089.42872593-1</gtr:outcomeId><gtr:partnerContribution>Supply the compound fund 2 post-doc RAs</gtr:partnerContribution><gtr:piContribution>We recruit and test participants for their response to Sunovion's new drug that is a possible new and very novel antipsychotic</gtr:piContribution><gtr:sector>Private</gtr:sector><gtr:start>2013-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Cardiff University</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>Brain Research Imaging Centre (CUBRIC)</gtr:department><gtr:description>MRC Spring study</gtr:description><gtr:id>FBE87376-59D5-49A3-8AC9-B6D75B97A914</gtr:id><gtr:impact>Just starting</gtr:impact><gtr:outcomeId>548ad7bab12940.31054402-2</gtr:outcomeId><gtr:partnerContribution>3 centre collaboration to recruit patients with early and established psychosis for biomarkers of glutamate, GABA neurochemistry and function in early psychosis</gtr:partnerContribution><gtr:piContribution>Cubric: magneto ecncepahalography (MEG) &amp;amp; magnetic resonance spectroscopy (MRS)
Nottingham: MEG and c13 MRS</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2013-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>AstraZeneca</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:description>AZ funded comparison ketamine vs AZD6765 phMRI</gtr:description><gtr:id>67F74014-4846-4DF5-8B27-895BB6D37EEB</gtr:id><gtr:impact>5 conference presentations and a poster prize.
I Publication PMID: 27133029</gtr:impact><gtr:outcomeId>LUwZoKMGB1T-1</gtr:outcomeId><gtr:partnerContribution>Funding for MRI scans and RA salaries and investigator time</gtr:partnerContribution><gtr:piContribution>The coop facilitated the development of a novel method of imaging the direct effects of a drug on brain function, called the p-block method of pharmaco MRI. This a potentially important way of evaluating the actions of new compounds in development.</gtr:piContribution><gtr:sector>Private</gtr:sector><gtr:start>2010-01-01</gtr:start></gtr:collaborationOutput></gtr:collaborationOutputs><gtr:disseminationOutputs><gtr:disseminationOutput><gtr:description>School visit</gtr:description><gtr:form>A formal working group, expert panel or dialogue</gtr:form><gtr:geographicReach>Local</gtr:geographicReach><gtr:id>70FE83CB-601C-423D-9744-5D512234BBDB</gtr:id><gtr:impact>Delivered lecture to a 6th form scientific society

recruited other speakers. Work experience</gtr:impact><gtr:outcomeId>9EC3546A6B3</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Schools</gtr:primaryAudience><gtr:year>2008</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Work experience</gtr:description><gtr:form>Participation in an open day or visit at my research institution</gtr:form><gtr:geographicReach>Local</gtr:geographicReach><gtr:id>5664A08C-F550-47DB-8839-9A62EEFF9E71</gtr:id><gtr:impact>hosted student for 2 weeks.

university course applied for in related area
Got into Nottingham Medical school</gtr:impact><gtr:outcomeId>51EDA438F64</gtr:outcomeId><gtr:partOfOfficialScheme>true</gtr:partOfOfficialScheme><gtr:primaryAudience>Schools</gtr:primaryAudience><gtr:year>2009</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>All in the Mind, Radio 4 item on ketamine for depression 	</gtr:description><gtr:form>A press release, press conference or response to a media enquiry/interview</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>E8ABB232-53F8-4560-872E-F4E5AEB25B43</gtr:id><gtr:impact>About 20 emails volunteering for experiments and trials or wanting clinical help for resistant depression.</gtr:impact><gtr:outcomeId>5463ea820923d2.19012767</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:year>2008</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Cafe Muse</gtr:description><gtr:form>A formal working group, expert panel or dialogue</gtr:form><gtr:geographicReach>Local</gtr:geographicReach><gtr:id>8A44FB30-7F35-42A4-81A2-BE2292D02B5D</gtr:id><gtr:impact>Lecture on fMRI
Talk on schizophrenia neurobiology
Talk on neurobiology of depression to 6th formers 


Collaboration with an artist instigated.
Medical undergraduate in audience came to do a Project Option with me. 
Very positive feedback from organisers and prolonged Q&amp;amp;A after Dalton talk</gtr:impact><gtr:outcomeId>77D9594D160</gtr:outcomeId><gtr:partOfOfficialScheme>true</gtr:partOfOfficialScheme><gtr:primaryAudience>Media (as a channel to the public)</gtr:primaryAudience><gtr:year>2008,2012,2013</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>British Computer Society</gtr:description><gtr:form>A formal working group, expert panel or dialogue</gtr:form><gtr:geographicReach>Local</gtr:geographicReach><gtr:id>BF74B6D7-C90F-4672-9EAF-ED8E753CD6F8</gtr:id><gtr:impact>Lecture with long Q&amp;amp;A

material was well received so decided to use again for less specialist audience</gtr:impact><gtr:outcomeId>DEE50B06319</gtr:outcomeId><gtr:partOfOfficialScheme>true</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:year>2008</gtr:year></gtr:disseminationOutput></gtr:disseminationOutputs><gtr:exploitationOutputs/><gtr:furtherFundingOutputs><gtr:furtherFundingOutput><gtr:amountPounds>237068</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Lundbeck commercial/academic</gtr:description><gtr:end>2013-12-02</gtr:end><gtr:fundingOrg>P1vital Consortium</gtr:fundingOrg><gtr:id>64686FD9-007B-4DDC-A07D-128C7855453E</gtr:id><gtr:outcomeId>5464b14c3fd894.75049805</gtr:outcomeId><gtr:sector>Private</gtr:sector><gtr:start>2012-06-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>300000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>project opiate</gtr:description><gtr:end>2011-04-02</gtr:end><gtr:fundingOrg>Medical Research Council (MRC)</gtr:fundingOrg><gtr:fundingRef>G1000018</gtr:fundingRef><gtr:id>F24F18DC-D1CC-4F02-9186-7ADDF128722A</gtr:id><gtr:outcomeId>4D045B6013E0</gtr:outcomeId><gtr:sector>Academic/University</gtr:sector><gtr:start>2009-05-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>554940</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Biomedical catalyst fund</gtr:description><gtr:end>2015-04-02</gtr:end><gtr:fundingOrg>Technology Strategy Board (TSB)</gtr:fundingOrg><gtr:id>AFBECA0C-CEA6-4852-8705-D7C4E17161FD</gtr:id><gtr:outcomeId>927E8B8935C0</gtr:outcomeId><gtr:sector>Public</gtr:sector><gtr:start>2013-05-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>528093</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Heptares Therapeutics Ltd</gtr:description><gtr:end>2017-03-02</gtr:end><gtr:fundingOrg>P1vital Consortium</gtr:fundingOrg><gtr:id>15FB3014-EF79-42B1-A639-ABB3E6A4C053</gtr:id><gtr:outcomeId>58c46e4a8c9445.46341390</gtr:outcomeId><gtr:sector>Private</gtr:sector></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>1000000</gtr:amountPounds><gtr:country>European Union (EU)</gtr:country><gtr:currCode>EUR</gtr:currCode><gtr:currCountryCode>Austria</gtr:currCountryCode><gtr:currLang>de_AT</gtr:currLang><gtr:description>FP6 Integrated Programme</gtr:description><gtr:end>2010-03-02</gtr:end><gtr:fundingOrg>Sixth Framework Programme (FP6)</gtr:fundingOrg><gtr:id>8D3EFFF4-9C20-4EBE-8845-AA371E1AF2F7</gtr:id><gtr:outcomeId>YxZEatDGaEs</gtr:outcomeId><gtr:sector>Public</gtr:sector><gtr:start>2004-01-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>517529</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Project resilience</gtr:description><gtr:fundingOrg>Medical Research Council (MRC)</gtr:fundingOrg><gtr:id>E6C826DA-E45F-4022-B7B4-7DD90650B489</gtr:id><gtr:outcomeId>1C466F6ED490</gtr:outcomeId><gtr:sector>Academic/University</gtr:sector><gtr:start>2009-11-01</gtr:start></gtr:furtherFundingOutput></gtr:furtherFundingOutputs><gtr:impactSummaryOutputs/><gtr:intellectualPropertyOutputs/><gtr:otherResearchOutputs/><gtr:policyInfluenceOutputs/><gtr:productOutputs/><gtr:researchDatabaseAndModelOutputs/><gtr:researchMaterialOutputs><gtr:researchMaterialOutput><gtr:description>methods developed to cross-correlate brain activity in the default mode</gtr:description><gtr:id>5F9B313A-5301-4889-9760-BE7743E01445</gtr:id><gtr:impact>Manuscript currently under preparation</gtr:impact><gtr:outcomeId>A37DA8CEB76</gtr:outcomeId><gtr:providedToOthers>false</gtr:providedToOthers><gtr:title>connectivity analysis</gtr:title><gtr:type>Model of mechanisms or symptoms - human</gtr:type></gtr:researchMaterialOutput><gtr:researchMaterialOutput><gtr:description>Publications about a new way of visualising and quantifying neurotransmitter function by experimental drug challenge in MRI scanner</gtr:description><gtr:id>A34BF601-40BA-4142-BDC5-A7D7249064EC</gtr:id><gtr:impact>Other groups use it</gtr:impact><gtr:outcomeId>9A3ABA2352A</gtr:outcomeId><gtr:providedToOthers>true</gtr:providedToOthers><gtr:title>p-block pharmaco MRI analysis method</gtr:title><gtr:type>Model of mechanisms or symptoms - human</gtr:type><gtr:yearFirstProvided>2008</gtr:yearFirstProvided></gtr:researchMaterialOutput></gtr:researchMaterialOutputs><gtr:softwareAndTechnicalProductOutputs/><gtr:spinOutOutputs><gtr:spinOutOutput><gtr:companyName>p1vital</gtr:companyName><gtr:description>www.p1vital.com 
Aims to develop biomarkers for CNS drug efficacy in early clinical development with academic departments and to use them in commercial studies with the pharmaceutical industry</gtr:description><gtr:id>4603BDEF-D889-4CFD-97DE-6BF7780B2F6B</gtr:id><gtr:impact>several academic and commercial projects with results presented at major international meeting in europe and the USA</gtr:impact><gtr:outcomeId>fH7aNd8Ja2q</gtr:outcomeId><gtr:url>http://www.p1vital.com</gtr:url></gtr:spinOutOutput></gtr:spinOutOutputs></gtr:output><gtr:publications><gtr:publication><gtr:id>EE85C89F-E9AF-4810-A924-035D17991ADE</gtr:id><gtr:title>Medial orbitofrontal cortex codes relative rather than absolute value of financial rewards in humans.</gtr:title><gtr:parentPublicationTitle>The European journal of neuroscience</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/c38adea8d377ccbaffd4d997c6d97747"><gtr:id>c38adea8d377ccbaffd4d997c6d97747</gtr:id><gtr:otherNames>Elliott R</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>0953-816X</gtr:issn><gtr:outcomeId>AB62FC1D2CF</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>F0964EDD-2606-4824-A47B-4052C23F60DC</gtr:id><gtr:title>Hedonic and informational functions of the human orbitofrontal cortex.</gtr:title><gtr:parentPublicationTitle>Cerebral cortex (New York, N.Y. : 1991)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/c38adea8d377ccbaffd4d997c6d97747"><gtr:id>c38adea8d377ccbaffd4d997c6d97747</gtr:id><gtr:otherNames>Elliott R</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>1047-3211</gtr:issn><gtr:outcomeId>3BB7A9BC8CD</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>D9D31173-AB5C-4F50-B3A4-573A8A15B772</gtr:id><gtr:title>Neuronal correlates and serotonergic modulation of behavioural inhibition and reward in healthy and antisocial individuals.</gtr:title><gtr:parentPublicationTitle>Journal of psychiatric research</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/05f96aa19676c2e32af9bfd7082525f0"><gtr:id>05f96aa19676c2e32af9bfd7082525f0</gtr:id><gtr:otherNames>V?llm B</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0022-3956</gtr:issn><gtr:outcomeId>Bgj4qT2Gx45</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>02F0918F-B4FF-42D8-8E68-BA96806131B9</gtr:id><gtr:title>Neuronal correlates of theory of mind and empathy: a functional magnetic resonance imaging study in a nonverbal task.</gtr:title><gtr:parentPublicationTitle>NeuroImage</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/b23def29a10695603aa425b394a802ae"><gtr:id>b23def29a10695603aa425b394a802ae</gtr:id><gtr:otherNames>V?llm BA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2006-01-01</gtr:date><gtr:issn>1053-8119</gtr:issn><gtr:outcomeId>24B60BD5005</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>DA22DDFD-EA30-499B-BEFB-2FD9674BD623</gtr:id><gtr:title>Co-operation with another player in a financially rewarded guessing game activates regions implicated in theory of mind.</gtr:title><gtr:parentPublicationTitle>Social neuroscience</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/c38adea8d377ccbaffd4d997c6d97747"><gtr:id>c38adea8d377ccbaffd4d997c6d97747</gtr:id><gtr:otherNames>Elliott R</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2006-01-01</gtr:date><gtr:issn>1747-0919</gtr:issn><gtr:outcomeId>0A150ADD6D7</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>B64426E1-A3D0-4562-BEDE-6CD39028D486</gtr:id><gtr:title>Analysis of connectivity in the resting state of the default mode of brain function: a major role for the cerebellum?</gtr:title><gtr:parentPublicationTitle>International Journal of Modelling, Identification and Control</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/b9c1d7cedd290827d991447ba12acb23"><gtr:id>b9c1d7cedd290827d991447ba12acb23</gtr:id><gtr:otherNames>Kong Y</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:outcomeId>RHNHFaLUgHd</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>0823334B-71B7-4B1A-B004-0295EFC95205</gtr:id><gtr:title>Neuronal correlates of reward and loss in Cluster B personality disorders: a functional magnetic resonance imaging study.</gtr:title><gtr:parentPublicationTitle>Psychiatry research</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/05f96aa19676c2e32af9bfd7082525f0"><gtr:id>05f96aa19676c2e32af9bfd7082525f0</gtr:id><gtr:otherNames>V?llm B</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2007-01-01</gtr:date><gtr:issn>0165-1781</gtr:issn><gtr:outcomeId>DzBK2oeognq</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>E4464B2B-7B8A-45DB-8D45-AE3189F4EF4C</gtr:id><gtr:title>A comparison of permutation and parametric testing for between group effective connectivity differences using DCM.</gtr:title><gtr:parentPublicationTitle>NeuroImage</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/31349e4bf5304659642021fc41e06aef"><gtr:id>31349e4bf5304659642021fc41e06aef</gtr:id><gtr:otherNames>Goulden N</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>1053-8119</gtr:issn><gtr:outcomeId>pm_15540_20_20004253</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>28893F74-3252-4B74-8921-E5B81F099779</gtr:id><gtr:title>Modulation of activity in swallowing motor cortex following esophageal acidification: a functional magnetic resonance imaging study.</gtr:title><gtr:parentPublicationTitle>Dysphagia</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/97c09f494770c86c24da875287e7e66c"><gtr:id>97c09f494770c86c24da875287e7e66c</gtr:id><gtr:otherNames>Paine PA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>0179-051X</gtr:issn><gtr:outcomeId>08720723791</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>76661A57-A56A-45FC-BA9C-0C1AC8594477</gtr:id><gtr:title>Glutamate and the neural basis of the subjective effects of ketamine: a pharmaco-magnetic resonance imaging study.</gtr:title><gtr:parentPublicationTitle>Archives of general psychiatry</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/43e3f8332e98da45abaf04771e46a10a"><gtr:id>43e3f8332e98da45abaf04771e46a10a</gtr:id><gtr:otherNames>Deakin JF</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>0003-990X</gtr:issn><gtr:outcomeId>4F80DD55EB9</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>C3D65660-361F-4BBD-9010-FF7CD65203F7</gtr:id><gtr:title>An investigation into aripiprazole's partial D2 agonist effects within the dorsolateral prefrontal cortex during working memory in healthy volunteers.</gtr:title><gtr:parentPublicationTitle>Psychopharmacology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/27fcd60488447ec2442bd8cacdc63faa"><gtr:id>27fcd60488447ec2442bd8cacdc63faa</gtr:id><gtr:otherNames>Murphy A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0033-3158</gtr:issn><gtr:outcomeId>58c41aca985059.31726042</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>1CE6A297-E95A-4963-98EE-9F7418D74951</gtr:id><gtr:title>Sample size estimation for comparing parameters using dynamic causal modeling.</gtr:title><gtr:parentPublicationTitle>Brain connectivity</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/31349e4bf5304659642021fc41e06aef"><gtr:id>31349e4bf5304659642021fc41e06aef</gtr:id><gtr:otherNames>Goulden N</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>2158-0014</gtr:issn><gtr:outcomeId>pm_15540_20_22559836</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>530C2789-F907-4B39-9FFD-221459BFFBA7</gtr:id><gtr:title>Assessing human 5-HT function in vivo with pharmacoMRI.</gtr:title><gtr:parentPublicationTitle>Neuropharmacology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/2fb15ce60d6a18431ae34975652c4485"><gtr:id>2fb15ce60d6a18431ae34975652c4485</gtr:id><gtr:otherNames>Anderson IM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>0028-3908</gtr:issn><gtr:outcomeId>AUqPx3rFkMY</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>4F41ED59-4063-4C99-808F-3B95F36450B3</gtr:id><gtr:title>Serotonergic modulation of neuronal responses to behavioural inhibition and reinforcing stimuli: an fMRI study in healthy volunteers.</gtr:title><gtr:parentPublicationTitle>The European journal of neuroscience</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/05f96aa19676c2e32af9bfd7082525f0"><gtr:id>05f96aa19676c2e32af9bfd7082525f0</gtr:id><gtr:otherNames>V?llm B</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2006-01-01</gtr:date><gtr:issn>0953-816X</gtr:issn><gtr:outcomeId>6EB02F25F46</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>362B6A06-2D3F-43E7-BE78-C16011B81540</gtr:id><gtr:title>Citalopram modulation of neuronal responses to aversive face emotions: a functional MRI study.</gtr:title><gtr:parentPublicationTitle>Neuroreport</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/2fb15ce60d6a18431ae34975652c4485"><gtr:id>2fb15ce60d6a18431ae34975652c4485</gtr:id><gtr:otherNames>Anderson IM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2007-01-01</gtr:date><gtr:issn>0959-4965</gtr:issn><gtr:outcomeId>3E41AA93353</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>1B804AD6-AAEC-47FB-A2C6-DFDB896CB515</gtr:id><gtr:title>A voxel-based morphometric MRI study in men with borderline personality disorder: preliminary findings.</gtr:title><gtr:parentPublicationTitle>Criminal behaviour and mental health : CBMH</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/b23def29a10695603aa425b394a802ae"><gtr:id>b23def29a10695603aa425b394a802ae</gtr:id><gtr:otherNames>V?llm BA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>0957-9664</gtr:issn><gtr:outcomeId>A8BF2FA89E3</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>6BECDE12-8B14-4DE2-A564-5215F100FAD0</gtr:id><gtr:title>Robust quantification of short echo time 1H magnetic resonance spectra using the Pad&amp;eacute; approximant.</gtr:title><gtr:parentPublicationTitle>Magnetic resonance in medicine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/f5dbc23c06f8ad557f6fb63c626a4604"><gtr:id>f5dbc23c06f8ad557f6fb63c626a4604</gtr:id><gtr:otherNames>Williamson DC</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2006-01-01</gtr:date><gtr:issn>0740-3194</gtr:issn><gtr:outcomeId>344EC82DC4C</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>693F9D77-0EBC-4622-8CDD-3184B883A053</gtr:id><gtr:title>A magnetic resonance spectroscopy study of brain glutamate in a model of plasticity in human pharyngeal motor cortex.</gtr:title><gtr:parentPublicationTitle>Gastroenterology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/fade14a3384de22ad83e51433c35ef62"><gtr:id>fade14a3384de22ad83e51433c35ef62</gtr:id><gtr:otherNames>Singh S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>0016-5085</gtr:issn><gtr:outcomeId>73D7C854E19</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>9799596F-53AC-4C74-9A17-3032F0244E63</gtr:id><gtr:title>The effect of citalopram pretreatment on neuronal responses to neuropsychological tasks in normal volunteers: an FMRI study.</gtr:title><gtr:parentPublicationTitle>Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/f3f466227064717d9f6e56af8dc9973b"><gtr:id>f3f466227064717d9f6e56af8dc9973b</gtr:id><gtr:otherNames>Del-Ben CM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2005-01-01</gtr:date><gtr:issn>0893-133X</gtr:issn><gtr:outcomeId>pm_15540_10_15827569</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>EF29812C-7775-4286-8D55-321B5583C9A7</gtr:id><gtr:title>Neuronal effects of acute citalopram detected by pharmacoMRI.</gtr:title><gtr:parentPublicationTitle>Psychopharmacology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/49468cecd48d416c6cf25e71c309faa0"><gtr:id>49468cecd48d416c6cf25e71c309faa0</gtr:id><gtr:otherNames>McKie S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2005-01-01</gtr:date><gtr:issn>0033-3158</gtr:issn><gtr:outcomeId>pm_15540_10_15889241</gtr:outcomeId></gtr:publication></gtr:publications><gtr:identifiers><gtr:identifier type="RCUK">G0300653</gtr:identifier></gtr:identifiers><gtr:healthCategories><gtr:healthCategory><gtr:id>A9061818-9B1E-495A-9617-7C77200827C2</gtr:id><gtr:percentage>10</gtr:percentage><gtr:text>Eye</gtr:text></gtr:healthCategory><gtr:healthCategory><gtr:id>3C193D18-12BD-4B15-8347-037BA623E0FF</gtr:id><gtr:percentage>10</gtr:percentage><gtr:text>Mental Health</gtr:text></gtr:healthCategory><gtr:healthCategory><gtr:id>041997EB-CFD8-493D-B0F8-DFA35451D0BE</gtr:id><gtr:percentage>70</gtr:percentage><gtr:text>Neurological</gtr:text></gtr:healthCategory><gtr:healthCategory><gtr:id>A77DAE3A-499B-4F46-971D-6C82F51F9C2E</gtr:id><gtr:percentage>10</gtr:percentage><gtr:text>Stroke</gtr:text></gtr:healthCategory></gtr:healthCategories><gtr:researchActivities><gtr:researchActivity><gtr:id>1BF330A9-C7B5-49C5-B54B-CF4FAE6DF1D8</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>2.1  Biological and endogenous factors</gtr:text></gtr:researchActivity></gtr:researchActivities><gtr:researchSubjects/><gtr:researchTopics/><gtr:rcukProgrammes/></gtr:project></gtr:projectComposition></gtr:projectOverview>